Mita, Tomoya
Katakami, Naoto
Yoshii, Hidenori
Onuma, Tomio
Kaneto, Hideaki
Osonoi, Takeshi
Shiraiwa, Toshihiko
Yasuda, Tetsuyuki
Umayahara, Yutaka
Yamamoto, Tsunehiko
Yokoyama, Hiroki
Kuribayashi, Nobuichi
Jinnouchi, Hideaki
Gosho, Masahiko
Shimomura, Iichiro
Watada, Hirotaka
Article History
Received: 9 June 2023
Accepted: 21 August 2023
First Online: 5 September 2023
Competing interests
: NKa was a staff member of the endowed chair established by funds from Kowa Co. Ltd., and has received lecture fees from Astellas Pharma Inc., AstraZeneca K.K., Daiichi Sankyo Inc., Eli Lilly Japan K. K, Kowa Company Ltd., Kyowa Hakko Kirin Co. Ltd., Mitsubishi Tanabe Pharma Co., Nippon Boehringer Ingelheim Co., Novartis Pharmaceuticals, Novo Nordisk Pharma, Ono Pharmaceutical Co., Taisho Toyama Pharmaceutical Co., Takeda Pharmaceutical Co., Teijin Pharma, Sanofi-Aventis, and Sumitomo Pharma Co. HK has received lecture fees from Boehringer Ingelheim, Sanofi-Aventis, Ono Pharmaceutical Co., MSD, Novo Nordisk Pharma, Novartis Pharmaceuticals, Daiichi Sankyo Inc., Takeda Pharmaceutical Co., Kissei Pharmaceutical Co., Sumitomo Pharma Co., Mitsubishi Tanabe Pharma Co., Kyowa Kirin, Eli Lilly, Pfizer, Astrazeneca, and Astellas Pharma Inc., and research funds from Boehringer Ingelheim, Sumitomo Pharma Co., and Taisho Pharma Co., and scholarship donations from Takeda Pharmaceutical Co., MSD, Mochida Pharmaceutical Co., Sanofi-Aventis, Novartis Pharmaceuticals, Novo Nordisk Pharma, Eli Lilly, Daiichi Sankyo Inc., Shionogi Pharma, Teijin Pharma, Sumitomo Pharma Co., Otsuka Pharmaceutical, Kissei Pharmaceutical Co., Mitsubishi Tanabe Pharma Co., Ono Pharmaceutical Co., Astrazeneca, Astellas Pbarma Inc., Kyowa Hakka Kirin Co. HJ has received lecture fees from Sanofi-Aventis, Sumitomo Pharma Co., Taisho Pharma Co., Eli Lilly, Boehringer Ingelheim, and Novo Nordisk Pharma, and research funds from Boehringer Ingelheim, Eli Lilly, and Novo Nordisk Pharma. NKu has received lecture fees from Novo Nordisk Pharma. MG has received lecture fees from Ferring Pharmaceuticals Co., Ltd, Merck Biopharma, and Pfizer. IS has received lecture fees from Amgen Astellas Biopharma K.K., Astellas Pharma Inc., AstraZeneca K.K., Covidien Japan Inc., Daiichi Sankyo Co., Eli Lilly Japan K.K, MSD K.K., KOBAYASHI Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Kirin Co., Ltd., Takeda Pharma K.K., Mitsubishi Tanabe Pharma Co., Mochida Pharmaceutical Co., Nippon Boehringer Ingelheim Co., Nippon Chemiphar Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma, Ono Pharmaceutical Co., Rohto Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Sumitomo Pharma Co., Taisho Pharmaceutical Co. Ltd., and Teijin Pharma; research funds from Astellas Pharma Inc., Cancerscan Inc., Daiichi Sankyo Co., Dainippon Sumitomo Pharma Co., Eli Lilly Japan K.K, Japan Agency for Medical Research and Development (AMED), Kaken Pharmaceutical Co., KOBAYASHI Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kubarahonke Co., Ltd., Kyowa Kirin Co., Ltd., Mitsubishi Tanabe Pharma Co., MSD K.K, Novartis Pharma K.K., Novo Nordisk Pharma, Ono Pharmaceutical Co., Rohto Pharmaceutical Co., Ltd. Sanofi K.K., Shionogi & Co., Takeda Pharma K.K., and Teijin Pharma; and scholarship donations from Daiichi Sankyo Co., Kowa Company, Ltd., Mitsubishi Tanabe Pharma Co., Mochida Pharmaceutical Co., Novo Nordisk Pharma, Sumitomo Pharma Co., Takeda Pharma K.K., and Teijin Pharma. HW has received honoraria for lectures for Bayer Pharma Japan, Teijin Pharma Ltd., MSD, Sanofi-Aventis K.K., Novo Nordisk, Nippon Boehringer Ingelheim, Eli Lilly, Sumitomo Pharma, Mitsubishi Tanabe Pharma, Daiichi Sankyo Company, Ltd., Abbott, Kowa Co., Ltd., Taisho Pharmaceutical, Astellas Pharma, Kissei Pharmaceutical Co., Ltd., AstraZeneca K.K., Ono Pharmaceutical Co. Ltd., Sanwa Kagaku, Takeda Pharmaceuticals, and research activities for Takeda Pharmaceuticals, Nippon Boehringer Ingelheim, Kissei Pharmaceutical, Novo Nordisk, Mitsubishi Tanabe Pharma, Lifescan Japan, Kyowa Kirin, Sumitomo Pharma, Eli Lilly, Teijin Pharma, Taisho Pharmaceutical, Abbott, Ono Pharmaceutical Co. Ltd., Soiken Inc., Sanwa Kagaku, and Kowa. Other authors have no competing interests.